shortagewatch

Home / Musculoskeletal system / Ketorolac

ATC M01AB15 · Acetic Acid Derivatives and Related Substances · updated 2 Nov 2026

Ketorolac shortage

As of 2 Nov 2026, Ketorolac has a reported shortage in 4 of the 16 countries we track (United States, Canada, Switzerland, Sweden), covering 30 products from 11 companies.

Is there a Ketorolac shortage?

Yes. As of 2 Nov 2026, Ketorolac is reported short in 4 of the 16 countries we track: United States, Canada, Switzerland, Sweden. The earliest expected return is 30 Sep 2027 (Sweden). 29 of 30 affected products have no return date.

Countries4/16
Products30packs or presentations
Companies116 listed
Short since10 Mar 20179.6 years ago
Earliest return30 Sep 2027company estimate
Main reasonNot stated
United States26 products shortCanada2 products shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerland1 product shortCzechiaNo reported shortageNorwayNo reported shortageSweden1 product shortJapanNo reported shortageNew ZealandNo reported shortageAustraliaNo reported shortage

Timeline

United StatesCanadaSwitzerlandSweden
202220232024202520262028Ketorolac Tromethamine, Injection, 15 mg/1 mKetorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01)Ketorolac Tromethamine, Injection, 15 mg/1 mKetorolac Tromethamine, Injection, 15 mg/1 mL (NDC 62332-599-25)Ketorolac Tromethamine, Injection, 15 mg/1 mKetorolac Tromethamine, Injection, 15 mg/1 mL (NDC 63323-161-01)Ketorolac Tromethamine, Injection, 15 mg/1 mKetorolac Tromethamine, Injection, 15 mg/1 mL (NDC 76045-107-10)Ketorolac Tromethamine, Injection, 30 mg/1 mKetorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01)Ketorolac Tromethamine, Injection, 30 mg/1 mKetorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02)Ketorolac Tromethamine, Injection, 30 mg/1 mKetorolac Tromethamine, Injection, 30 mg/1 mL (NDC 62332-600-25)Ketorolac Tromethamine, Injection, 30 mg/1 mKetorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-01)Ketorolac Tromethamine, Injection, 30 mg/1 mKetorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-02)Ketorolac Tromethamine, Injection, 30 mg/1 mKetorolac Tromethamine, Injection, 30 mg/1 mL (NDC 76045-104-10)Ketorolac Tromethamine, Injection, 60 mg/2 mKetorolac Tromethamine, Injection, 60 mg/2 mL (NDC 62332-601-25)Ketorolac Tromethamine, Injection, 60 mg/2 mKetorolac Tromethamine, Injection, 60 mg/2 mL (NDC 76045-105-20)Ketorolac Tromethamine, Injection, 15 mg/1 mKetorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0409-3793-01)Ketorolac Tromethamine, Injection, 15 mg/1 mKetorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01)Ketorolac Tromethamine, Injection, 30 mg/1 mKetorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01)Ketorolac Tromethamine, Injection, 30 mg/1 mKetorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01)Ketorolac Tromethamine, Injection, 30 mg/1 mKetorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02)Ketorolac Tromethamine, Injection, 60 mg/2 mKetorolac Tromethamine, Injection, 60 mg/2 mL (30 mg/mL) (NDC 0409-3796-01)Ketorolac Tromethamine, Injection, 15 mg/1 mKetorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10)Ketorolac Tromethamine, Injection, 15 mg/1 mKetorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0641-6041-25)Ketorolac Tromethamine, Injection, 30 mg/1 mKetorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25)Ketorolac Tromethamine, Injection, 30 mg/1 mKetorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6042-25)Ketorolac Tromethamine, Injection, 30 mg/1 mKetorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6043-25)Ketorolac Tromethamine, Injection, 30 mg/1 mKetorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-118-25)Ketorolac Tromethamine, Injection, 30 mg/1 mKetorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-119-25)Ketorolac Tromethamine, Tablet, 10 mg (NDC 0Ketorolac Tromethamine, Tablet, 10 mg (NDC 0378-1134-01)APO-KETOROLAC INJECTABLE (1 ML)APO-KETOROLAC INJECTABLE (1 ML)KETOROLAC TROMETHAMINE INJECTION, USP (1 mL)KETOROLAC TROMETHAMINE INJECTION, USP (1 mL)TORA-DOL Inj Lös 30 mg/ml 5 Amp 1 mlTORA-DOL Inj Lös 30 mg/ml 5 Amp 1 mlCaloket 30 mg/ml Ampull, 6 x 1 mlCaloket 30 mg/ml Ampull, 6 x 1 mltoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Fresenius Kabi7 FREGland5Alembic3 APLLTDPfizer3 PFESagent3Hikma3 HIKBaxter2 BAXViatris1 VTRSApotex1Atnahs Switzerland1Eql1

Listed: Alembic APLLTD · NSE, Fresenius Kabi FRE · Xetra, Pfizer PFE · NYSE, Baxter BAX · NYSE, Hikma HIK · LSE, Viatris VTRS · Nasdaq

Compared with similar medicines

ATC group M01AB · Acetic Acid Derivatives and Related Substances
Diclofenac10/16Indometacin4/16Ketorolac4/16Aceclofenac3/16Diclofenac, Combinations1/16Etodolac1/16

Affected products

CountryProductCompanySinceExpected backReason
USKetorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01)Gland Pharma Limited23 Mar 2018not givenNot stated
USKetorolac Tromethamine, Injection, 15 mg/1 mL (NDC 62332-599-25)Alembic Pharmaceuticals23 Mar 2018not givenNot stated
USKetorolac Tromethamine, Injection, 15 mg/1 mL (NDC 63323-161-01)Fresenius Kabi USA, LLC23 Mar 2018not givenNot stated
USKetorolac Tromethamine, Injection, 15 mg/1 mL (NDC 76045-107-10)Fresenius Kabi USA, LLC23 Mar 2018not givenOther
USKetorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01)Gland Pharma Limited23 Mar 2018not givenNot stated
USKetorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02)Gland Pharma Limited23 Mar 2018not givenNot stated
USKetorolac Tromethamine, Injection, 30 mg/1 mL (NDC 62332-600-25)Alembic Pharmaceuticals23 Mar 2018not givenNot stated
USKetorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-01)Fresenius Kabi USA, LLC23 Mar 2018not givenDistribution or logistics
Delay in shipping of the drug
USKetorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-02)Fresenius Kabi USA, LLC23 Mar 2018not givenDistribution or logistics
Delay in shipping of the drug
USKetorolac Tromethamine, Injection, 30 mg/1 mL (NDC 76045-104-10)Fresenius Kabi USA, LLC23 Mar 2018not givenOther
USKetorolac Tromethamine, Injection, 60 mg/2 mL (NDC 62332-601-25)Alembic Pharmaceuticals23 Mar 2018not givenNot stated
USKetorolac Tromethamine, Injection, 60 mg/2 mL (NDC 76045-105-20)Fresenius Kabi USA, LLC23 Mar 2018not givenOther
USKetorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0409-3793-01)Hospira, Inc., a Pfizer Company26 Mar 2018not givenOther
USKetorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01) limitedSagent Pharmaceuticals26 Mar 2018not givenDistribution or logistics
Delay in shipping of the drug
USKetorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01)Hospira, Inc., a Pfizer Company26 Mar 2018not givenOther
USKetorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01)Sagent Pharmaceuticals26 Mar 2018not givenNot stated
USKetorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02)Sagent Pharmaceuticals26 Mar 2018not givenNot stated
USKetorolac Tromethamine, Injection, 60 mg/2 mL (30 mg/mL) (NDC 0409-3796-01)Hospira, Inc., a Pfizer Company26 Mar 2018not givenOther
USKetorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10)Baxter Healthcare6 Jun 2018not givenIncreased demand
Demand increase for the drug
USKetorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0641-6041-25)Hikma Pharmaceuticals USA, Inc.6 Jun 2018not givenOther
USKetorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25)Baxter Healthcare6 Jun 2018not givenNot stated
USKetorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6042-25)Hikma Pharmaceuticals USA, Inc.6 Jun 2018not givenOther
USKetorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6043-25)Hikma Pharmaceuticals USA, Inc.6 Jun 2018not givenOther
USKetorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-118-25)Gland Pharma Limited6 Jun 2018not givenNot stated
USKetorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-119-25)Gland Pharma Limited6 Jun 2018not givenNot stated
USKetorolac Tromethamine, Tablet, 10 mg (NDC 0378-1134-01) discontinuationMylan Pharmaceuticals Inc., a Viatris Company20 Apr 2026not givenNot stated
CAAPO-KETOROLAC INJECTABLE (1 ML)APOTEX INC10 Mar 2017not givenOther
Other (Please describe in comments)
CAKETOROLAC TROMETHAMINE INJECTION, USP (1 mL)FRESENIUS KABI CANADA LTD20 Mar 2026not givenManufacturing problem
Disruption of the manufacture of the drug
CHTORA-DOL Inj Lös 30 mg/ml 5 Amp 1 mlAtnahs Pharma Switzerland AG20 May 2026not givenNot stated
SECaloket 30 mg/ml Ampull, 6 x 1 mlEQL Pharma AB1 Aug 202430 Sep 2027Not stated

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Questions

Is there a Ketorolac shortage?

Yes. As of 2 Nov 2026, Ketorolac is reported short in 4 of the 16 countries we track: United States, Canada, Switzerland, Sweden. The earliest expected return is 30 Sep 2027 (Sweden). 29 of 30 affected products have no return date.

When will Ketorolac be back in stock?

Companies expect supply back from 30 Sep 2027 in Sweden; United States: no date given; Canada: no date given; Switzerland: no date given; Sweden: 30 Sep 2027. These are company estimates reported to each authority.

Why is Ketorolac in short supply?

The most common reason reported is: not stated. Reasons by product are listed in the table below.

Which companies have Ketorolac shortages?

Fresenius Kabi, Gland, Alembic, Pfizer, Sagent, Hikma, Baxter, Viatris, Apotex, Atnahs Switzerland.